CollPlant Biotechnologies (CLGN) Gross Profit Growth (3y) (2020 - 2026)
CollPlant Biotechnologies (CLGN) Gross Profit Growth (3y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 54.36% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 7.16% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 3.86% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 79.18% |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | CollPlant Biotechnologies | 4.63 Mn | 4.63 Mn | -243,000.00 | -61.98% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 30, 2026 | -61.98% |
| Dec 31, 2025 | -220.75% |
| Sep 30, 2025 | -7.40% |
| Jun 30, 2025 | -6,626.53% |
| Mar 30, 2025 | 276.44% |
| Dec 31, 2024 | 23.16% |
| Sep 30, 2024 | 94.88% |
| Jun 30, 2024 | -45.74% |
| Mar 31, 2024 | -26.68% |
| Dec 31, 2023 | -29.09% |
| Sep 30, 2023 | -346.16% |
| Jun 30, 2023 | 403.43% |
| Mar 31, 2023 | -6.94% |
| Dec 31, 2022 | -26.94% |
| Sep 30, 2022 | -87.19% |
| Jun 30, 2022 | -45.62% |
| Mar 31, 2022 | -41.41% |
| Dec 31, 2021 | -27.23% |
| Sep 30, 2021 | -2,282.01% |
| Jun 30, 2021 | 31.58% |